New Hampshirerelative to increasing transparency in the 340B Drug Pricing Program.
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Mar 5Refer to Interim Study, MA, VV; 03/05/2026; SJ 5Latest
- Feb 19Committee Report: Referred to Interim Study, 03/05/2026, Vote 5-0; SC 8
- Feb 19Special Order to the Next Session, Without Objection, MA; 02/19/2026; SJ 4
- Feb 19SB 477 was Removed from the Consent Calendar; 02/19/2026; SJ 4
- Feb 12Committee Report: Referred to Interim Study, 02/19/2026; Vote 5-0; CC; SC 6
- Jan 12Hearing: 01/21/2026, Room 100, SH, 01:30 pm; SC 2
- 2025
- Nov 21Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1Introduced